ArticleOrphanet journal of rare diseases2026
Methodological challenges in Dutch HTA of non-oncological orphan drugs: a retrospective analysis and price comparison using different pricing models.
Jelle Walraven et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.